Trends in prognosis and use of SGLT2i and GLP-1 RA in patients with diabetes and coronary artery disease.

ABSTRACT:

Objective

To explore trends in prognosis and use of glucose-lowering drugs (GLD) in patients with diabetes and coronary artery disease (CAD).

Research design and methods

All patients with diabetes and CAD undergoing a coronary angiography between 2010 and 2021 according to the Swedish Angiography and Angioplasty Registry were included. Information on GLD (dispended 6 months before or after coronary angiography) was collected from the Swedish Prescribed Drug Registry. Data on major cardiovascular events (MACE; mortality, myocardial infarction, stroke, heart failure) through December 2021 were obtained from national registries. Cox proportional survival analysis was used to assess outcomes where cardioprotective GLD (any of Sodium Glucose Lowering Transport 2 receptor inhibito

SUBMITTER: Ritsinger V 

PROVIDER: S-EPMC11304712 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature